Circulating mesenchymal stem cells CA Roufosse, NC Direkze, WR Otto, NA Wright The international journal of biochemistry & cell biology 36 (4), 585-597, 2004 | 409 | 2004 |
Bone marrow‐derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome EI Prodromidi, R Poulsom, R Jeffery, CA Roufosse, PJ Pollard, CD Pusey, ... Stem cells 24 (11), 2448-2455, 2006 | 273 | 2006 |
De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy M Willicombe, P Brookes, R Sergeant, E Santos-Nunez, C Steggar, ... Transplantation 94 (2), 172-177, 2012 | 264 | 2012 |
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy GM Lord, M Hollstein, VM Arlt, C Roufosse, CD Pusey, T Cook, ... American Journal of Kidney Diseases 43 (4), e18. 1-e18. 7, 2004 | 169 | 2004 |
Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma P Vermylen, C Roufosse, A Burny, A Verhest, T Bosschaerts, ... European Respiratory Journal 14 (4), 806-811, 1999 | 134 | 1999 |
Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor‐Specific Antibodies H De Kort, M Willicombe, P Brookes, KM Dominy, E Santos‐Nunez, ... American Journal of Transplantation 13 (2), 485-492, 2013 | 119 | 2013 |
Bone marrow–derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis C Roufosse, G Bou-Gharios, E Prodromidi, C Alexakis, R Jeffery, S Khan, ... Journal of the American Society of Nephrology 17 (3), 775-782, 2006 | 102 | 2006 |
Detection of bronchial preneoplastic lesions and early lung cancer with fluorescence bronchoscopy: a study about its ambulatory feasibility under local anaesthesis P Vermylen, P Pierard, C Roufosse, T Bosschaerts, A Verhest, JP Sculier, ... Lung cancer 25 (3), 161-168, 1999 | 96 | 1999 |
Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer P Pierard, P Vermylen, T Bosschaerts, C Roufosse, T Berghmans, ... Chest 117 (3), 779-785, 2000 | 90 | 2000 |
Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts C Lawrence, M Willicombe, PA Brookes, E Santos-Nunez, R Bajaj, ... Transplantation 95 (2), 341-346, 2013 | 78 | 2013 |
Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy M Willicombe, P Brookes, E Santos-Nunez, J Galliford, A Ballow, ... American Journal of Transplantation 11 (3), 470-477, 2011 | 72 | 2011 |
Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy—an open label, randomized trial K Chan, D Taube, C Roufosse, T Cook, P Brookes, D Goodall, J Galliford, ... Transplantation 92 (7), 774-780, 2011 | 64 | 2011 |
Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice VM Arlt, J Zuo, K Trenz, CA Roufosse, GM Lord, JL Nortier, HH Schmeiser, ... International journal of cancer 128 (1), 21-32, 2011 | 63 | 2011 |
Stem cells and renal regeneration C Roufosse, HT Cook Nephron Experimental Nephrology 109 (2), e39-e45, 2008 | 59 | 2008 |
Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome M Willicombe, C Roufosse, P Brookes, JW Galliford, AG Mclean, A Dorling, ... Transplantation 92 (2), 176-182, 2011 | 58 | 2011 |
Pathological predictors of prognosis in immunoglobulin A nephropathy: a review CA Roufosse, HT Cook Current opinion in nephrology and hypertension 18 (3), 212-219, 2009 | 56 | 2009 |
Subcutaneous panniculitis‐like T‐cell lymphoma: further evidence for a distinct neoplasm originating from large granular lymphocytes of T/NK phenotype JL Dargent, C Roufosse, JP Delville, A Kentos, J Delplace, A Kornreich, ... Journal of cutaneous pathology 25 (7), 394-400, 1998 | 48 | 1998 |
Development of a calcifying fibrous pseudotumour within a lesion of Castleman disease, hyaline-vascular subtype. JL Dargent, J Delplace, C Roufosse, JP Laget, L Lespagnard Journal of clinical pathology 52 (7), 547-549, 1999 | 41 | 1999 |
Lupus podocytopathy P Shea-Simonds, TD Cairns, C Roufosse, T Cook, TJ Vyse Rheumatology 48 (12), 1616-1618, 2009 | 40 | 2009 |
Pancreas transplantation, antibodies and rejection: where do we stand? H de Kort, C Roufosse, IM Bajema, CB Drachenberg Current Opinion in Organ Transplantation 18 (3), 337-344, 2013 | 37 | 2013 |